Impact of Neutrophil Extracellular Traps Identified by Citrullinated Histone H3 Immunohistochemistry for Postoperative Prognosis in Patients with Extrahepatic Cholangiocarcinomas.
Journal
Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840
Informations de publication
Date de publication:
05 Dec 2023
05 Dec 2023
Historique:
received:
18
04
2023
accepted:
07
11
2023
medline:
6
12
2023
pubmed:
6
12
2023
entrez:
5
12
2023
Statut:
aheadofprint
Résumé
Neutrophil extracellular traps (NETs) are extracellular chromatin structures composed of cytoplasmic, granular, and nuclear components of neutrophils. Recently, NETs have received much attention for their role in tumor biology; however, their impact on the postoperative prognosis of patients with extrahepatic cholangiocarcinomas (EHCCs) remains unclear. The purpose of this study was to clarify the impact of NETs identified by immunohistochemical citrullinated histone H3 (Cit-H3) staining on postoperative overall survival (OS) in patients with perihilar cholangiocarcinoma (PHCC) and distal cholangiocarcinoma (DCC). This study included 318 patients with EHCC (PHCC, n = 192; DCC, n = 126) who underwent surgical resection with curative intent. Neutrophils and NETs were identified by immunohistochemistry using antibodies against CD15 and Cit-H3, respectively. Based on the distribution of CD15 and Cit-H3 expression in the tumor bed, the patients were classified into four groups: one negative group and three subgroups of the positive group (diffuse, intermediate, and focal subgroups). No significant difference was found in the postoperative OS rate depending on the distribution of CD15 expression in patients with PHCC or DCC. However, the three subgroups with positive Cit-H3 expression had significantly poorer OS than the negative group for both PHCC and DCC. Moreover, positive Cit-H3 was an independent OS factor in the multivariable analyses of PHCC (hazard ratio [HR] 1.69, 95% confidence interval [CI] 1.11-2.59, P = 0.0115) and DCC (HR 2.03; 95% CI 1.21-3.42, P = 0.0057). The presence of NETs in the tumor microenvironment may have adverse prognostic effects in patients with EHCCs.
Sections du résumé
BACKGROUND
BACKGROUND
Neutrophil extracellular traps (NETs) are extracellular chromatin structures composed of cytoplasmic, granular, and nuclear components of neutrophils. Recently, NETs have received much attention for their role in tumor biology; however, their impact on the postoperative prognosis of patients with extrahepatic cholangiocarcinomas (EHCCs) remains unclear. The purpose of this study was to clarify the impact of NETs identified by immunohistochemical citrullinated histone H3 (Cit-H3) staining on postoperative overall survival (OS) in patients with perihilar cholangiocarcinoma (PHCC) and distal cholangiocarcinoma (DCC).
METHODS
METHODS
This study included 318 patients with EHCC (PHCC, n = 192; DCC, n = 126) who underwent surgical resection with curative intent. Neutrophils and NETs were identified by immunohistochemistry using antibodies against CD15 and Cit-H3, respectively. Based on the distribution of CD15 and Cit-H3 expression in the tumor bed, the patients were classified into four groups: one negative group and three subgroups of the positive group (diffuse, intermediate, and focal subgroups).
RESULTS
RESULTS
No significant difference was found in the postoperative OS rate depending on the distribution of CD15 expression in patients with PHCC or DCC. However, the three subgroups with positive Cit-H3 expression had significantly poorer OS than the negative group for both PHCC and DCC. Moreover, positive Cit-H3 was an independent OS factor in the multivariable analyses of PHCC (hazard ratio [HR] 1.69, 95% confidence interval [CI] 1.11-2.59, P = 0.0115) and DCC (HR 2.03; 95% CI 1.21-3.42, P = 0.0057).
CONCLUSIONS
CONCLUSIONS
The presence of NETs in the tumor microenvironment may have adverse prognostic effects in patients with EHCCs.
Identifiants
pubmed: 38052736
doi: 10.1245/s10434-023-14638-2
pii: 10.1245/s10434-023-14638-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. Society of Surgical Oncology.
Références
Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15:e493-503.
pubmed: 25281468
doi: 10.1016/S1470-2045(14)70263-3
Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 2009;30:1073–81.
pubmed: 19468060
doi: 10.1093/carcin/bgp127
Smith HA, Kang Y. The metastasis-promoting roles of tumor-associated immune cells. J Mol Med (Berl). 2013;91:411–29.
pubmed: 23515621
doi: 10.1007/s00109-013-1021-5
Shao BZ, Yao Y, Li JP, Chai NL, Linghu EQ. The role of neutrophil extracellular traps in cancer. Front Oncol. 2021;11:714357.
pubmed: 34476216
pmcid: 8406742
doi: 10.3389/fonc.2021.714357
Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303:1532–5.
pubmed: 15001782
doi: 10.1126/science.1092385
Saffarzadeh M, Juenemann C, Queisser MA, et al. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS ONE. 2012;7:e32366.
pubmed: 22389696
pmcid: 3289648
doi: 10.1371/journal.pone.0032366
Cools-Lartigue J, Spicer J, Najmeh S, Ferri L. Neutrophil extracellular traps in cancer progression. Cell Mol Life Sci. 2014;71:4179–94.
pubmed: 25070012
pmcid: 7096049
doi: 10.1007/s00018-014-1683-3
Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol. 2018;18:134–47.
pubmed: 28990587
doi: 10.1038/nri.2017.105
Jorch SK, Kubes P. An emerging role for neutrophil extracellular traps in noninfectious disease. Nat Med. 2017;23:279–87.
pubmed: 28267716
doi: 10.1038/nm.4294
Anderson CD, Pinson CW, Berlin J, Chari RS. Diagnosis and treatment of cholangiocarcinoma. Oncologist. 2004;9:43–57.
pubmed: 14755014
doi: 10.1634/theoncologist.9-1-43
Amin MB, Edge SB, Greene FL. AJCC cancer staging manual. 8th edn. New York: Springer; 2017.
doi: 10.1007/978-3-319-40618-3
Banales JM, Marin JJG, Lamarca A, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17:557–88.
pubmed: 32606456
pmcid: 7447603
doi: 10.1038/s41575-020-0310-z
van der Gaag NA, Kloek JJ, de Bakker JK, et al. Survival analysis and prognostic nomogram for patients undergoing resection of extrahepatic cholangiocarcinoma. Ann Oncol. 2012;23:2642–9.
pubmed: 22532585
doi: 10.1093/annonc/mds077
Nakanishi Y, Okamura K, Tsuchikawa T, et al. Time to recurrence after surgical resection and survival after recurrence among patients with perihilar and distal cholangiocarcinomas. Ann Surg Oncol. 2020;27:4171–80. https://doi.org/10.1245/s10434-020-08534-2
doi: 10.1245/s10434-020-08534-2
pubmed: 32363510
Akita M, Ajiki T, Matsumoto T, et al. Preoperative cholangitis affects survival outcome in patients with extrahepatic bile duct cancer. J Gastrointest Surg. 2017;21:983–9.
pubmed: 28290140
doi: 10.1007/s11605-017-3388-z
Wang Y, Fu W, Tang Z, Meng W, Zhou W, Li X. Effect of preoperative cholangitis on prognosis of patients with hilar cholangiocarcinoma: a systematic review and meta-analysis. Medicine (Baltimore). 2018;97:e12025.
pubmed: 30142851
doi: 10.1097/MD.0000000000012025
Cho JY, Han HS, Yoon YS, et al. Preoperative cholangitis and metastatic lymph node have a negative impact on survival after resection of extrahepatic bile duct cancer. World J Surg. 2012;36:1842–7.
pubmed: 22526039
doi: 10.1007/s00268-012-1594-0
Wu X, Takekoshi T, Sullivan A, Hwang ST. Inflammation and tumor microenvironment in lymph node metastasis. Cancers. 2011;3:927–44.
pubmed: 24212647
pmcid: 3756397
doi: 10.3390/cancers3010927
Karin M. Nuclear factor-κB in cancer development and progression. Nature. 2006;441:431–6.
pubmed: 16724054
doi: 10.1038/nature04870
Kiriyama S, Kozaka K, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci. 2018;25:17–30.
pubmed: 29032610
doi: 10.1002/jhbp.512
Nakazawa D, Tomaru U, Suzuki A, et al. Abnormal conformation and impaired degradation of propylthiouracil-induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2012;64:3779–87.
pubmed: 22777766
doi: 10.1002/art.34619
Yoshida M, Sasaki M, Sugisaki K, Yamaguchi Y, Yamada M. Neutrophil extracellular trap components in fibrinoid necrosis of the kidney with myeloperoxidase-ANCA-associated vasculitis. Clin Kidney J. 2013;6:308–12.
pubmed: 26064491
pmcid: 4400491
doi: 10.1093/ckj/sft048
Nakazawa D, Shida H, Tomaru U, et al. Enhanced formation and disordered regulation of NETs in myeloperoxidase-ANCA–associated microscopic polyangiitis. J Am Soc Nephrol. 2014;25:990–7.
pubmed: 24385592
pmcid: 4005303
doi: 10.1681/ASN.2013060606
Masuda S, Nakazawa D, Shida H, et al. NETosis markers: quest for specific, objective, and quantitative markers. Clin Chim Acta. 2016;459:89–93.
pubmed: 27259468
doi: 10.1016/j.cca.2016.05.029
Mousset A, Lecorgne E, Bourget I, et al. Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-β activation. Cancer Cell. 2023;41:757-75.e10.
pubmed: 37037615
doi: 10.1016/j.ccell.2023.03.008
Zhang H, Lv H, Weng M, et al. Preoperative leukocytosis is associated with increased tumor-infiltrating neutrophil extracellular traps and worse outcomes in esophageal cancer. Ann Transl Med. 2020;8:441.
pubmed: 32395485
pmcid: 7210211
doi: 10.21037/atm.2020.03.190
Jin W, Xu HX, Zhang SR, et al. Tumor-infiltrating NETs predict postsurgical survival in patients with pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2019;26:635–43. https://doi.org/10.1245/s10434-018-6941-4
doi: 10.1245/s10434-018-6941-4
pubmed: 30374923
Tohme S, Yazdani HO, Al-Khafaji AB, et al. Neutrophil extracellular traps promote the development and progression of liver metastases after surgical stress. Cancer Res. 2016;76:1367–80.
pubmed: 26759232
pmcid: 4794393
doi: 10.1158/0008-5472.CAN-15-1591
Zhang Y, Hu Y, Ma C, et al. Diagnostic, therapeutic predictive, and prognostic value of neutrophil extracellular traps in patients with gastric adenocarcinoma. Front Oncol. 2020;10:1036.
pubmed: 32714865
pmcid: 7344202
doi: 10.3389/fonc.2020.01036
Park J, Wysocki RW, Amoozgar Z, et al. Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps. Sci Transl Med. 2016;8:361–138.
doi: 10.1126/scitranslmed.aag1711
Arelaki S, Arampatzioglou A, Kambas K, et al. Gradient infiltration of neutrophil extracellular traps in colon cancer and evidence for their involvement in tumour growth. PLoS ONE. 2016;11:e0154484.
pubmed: 27136460
pmcid: 4852909
doi: 10.1371/journal.pone.0154484
Li M, Lin C, Leso A, Nefedova Y. Quantification of citrullinated histone H3 bound DNA for detection of neutrophil extracellular traps. Cancers. 2020;12:3424.
pubmed: 33218159
pmcid: 7698949
doi: 10.3390/cancers12113424
Yoshikawa-Kimura A, Taira K, Maruyama H, et al. Influence of a biliary stent in patients with advanced pancreatic cancer treated with modified FOLFIRINOX. Medicine (Baltimore). 2022;101:e32150.
pubmed: 36626539
doi: 10.1097/MD.0000000000032150
Fridlender ZG, Albelda SM. Tumor-associated neutrophils: friend or foe? Carcinogenesis. 2012;33:949–55.
pubmed: 22425643
doi: 10.1093/carcin/bgs123
Granot Z, Jablonska J. Distinct functions of neutrophil in cancer and its regulation. Mediators Inflamm. 2015;701067.
Wu L, Saxena S, Awaji M, Singh RK. Tumor-associated neutrophils in cancer: going pro. Cancers. 2019;11:564.
pubmed: 31010242
pmcid: 6520693
doi: 10.3390/cancers11040564
Li P, Li M, Lindberg MR, Kennett MJ, Xiong N, Wang Y. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med. 2010;207:1853–62.
pubmed: 20733033
pmcid: 2931169
doi: 10.1084/jem.20100239
Oto J, Navarro S, Larsen AC, et al. MicroRNAs and neutrophil activation markers predict venous thrombosis in pancreatic ductal adenocarcinoma and distal extrahepatic cholangiocarcinoma. Int J Mol Sci. 2020;21:840.
pubmed: 32012923
pmcid: 7043221
doi: 10.3390/ijms21030840
Demkow U. Neutrophil extracellular traps (NETs) in cancer invasion, evasion and metastasis. Cancers. 2021;13:4495.
pubmed: 34503307
pmcid: 8431228
doi: 10.3390/cancers13174495
Thålin C, Hisada Y, Lundström S, Mackman N, Wallén H. Neutrophil extracellular traps: villains and targets in arterial, venous, and cancer-associated thrombosis. Arterioscler Thromb Vasc Biol. 2019;39:1724–38.
pubmed: 31315434
pmcid: 6703916
doi: 10.1161/ATVBAHA.119.312463
Chen YX, Han LL, Qiu XY, Wang G, Zheng JN. Neutrophil extracellular traps in digestive cancers: warrior or accomplice. Front Oncol. 2021;11:766636.
pubmed: 34868992
pmcid: 8639597
doi: 10.3389/fonc.2021.766636
Yang L, Liu Q, Zhang X, et al. DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25. Nature. 2020;583:133–8.
pubmed: 32528174
doi: 10.1038/s41586-020-2394-6
Cai Z, Zhang M, Boafo Kwantwi L, et al. Breast cancer cells promote self-migration by secreting interleukin 8 to induce NET formation. Gene. 2020;754:144902.
pubmed: 32544496
doi: 10.1016/j.gene.2020.144902
Lerman I, Hammes SR. Neutrophil elastase in the tumor microenvironment. Steroids. 2018;133:96–101.
pubmed: 29155217
doi: 10.1016/j.steroids.2017.11.006
Okeke EB, Louttit C, Fry C, et al. Inhibition of neutrophil elastase prevents neutrophil extracellular trap formation and rescues mice from endotoxic shock. Biomaterials. 2020;238:119836.
pubmed: 32045782
pmcid: 7075277
doi: 10.1016/j.biomaterials.2020.119836
Cools-Lartigue J, Spicer J, McDonald B, et al. Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J Clin Investig. 2013;123:3446–58.
pubmed: 23863628
pmcid: 3726160
doi: 10.1172/JCI67484
Leal AC, Mizurini DM, Gomes T, et al. Tumor-derived exosomes induce the formation of neutrophil extracellular traps: implications for the establishment of cancer-associated thrombosis. Sci Rep. 2017;7:6438.
pubmed: 28743887
pmcid: 5526939
doi: 10.1038/s41598-017-06893-7